Novamind to be featured in panel discussion on the disruptive potential of psychedelic medicine in mental healthcare

Toronto, Ontario--(Newsfile Corp. - September 29, 2021) - Novamind Inc. (CSE: NM) (OTCQB: NVMDF) (FSE: HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will participate in the...